Cite
Kawano S, Grassian AR, Tsuda M, et al. Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS One. 2017;12(1):e0170539doi: 10.1371/journal.pone.0170539.
Kawano, S., Grassian, A. R., Tsuda, M., Knutson, S. K., Warholic, N. M., Kuznetsov, G., Xu, S., Xiao, Y., Pollock, R. M., Smith, J. J., Kuntz, K. W., Ribich, S., Minoshima, Y., Matsui, J., Copeland, R. A., Tanaka, S., & Keilhack, H. (2017). Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PloS one, 12(1), e0170539. https://doi.org/10.1371/journal.pone.0170539
Kawano, Satoshi, et al. "Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma." PloS one vol. 12,1 (2017): e0170539. doi: https://doi.org/10.1371/journal.pone.0170539
Kawano S, Grassian AR, Tsuda M, Knutson SK, Warholic NM, Kuznetsov G, Xu S, Xiao Y, Pollock RM, Smith JJ, Kuntz KW, Ribich S, Minoshima Y, Matsui J, Copeland RA, Tanaka S, Keilhack H. Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS One. 2017 Jan 13;12(1):e0170539. doi: 10.1371/journal.pone.0170539. eCollection 2017. PMID: 28085948; PMCID: PMC5234811.
Copy
Download .nbib